Vincent Capponi, Chief Operating Officer at Cytosorbents Corp (CTSO), sold 4,846 shares at $9.00 ($44K) on 2018-05-16, disclosed to the SEC on 2018-05-18.
Scheduled sale ($44k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CTSO | BUY | 2022-06-22 | $4K | — | Filing → |
| CTSO | BUY | 2022-06-21 | $6K | — | Filing → |
| CTSO | BUY | 2022-05-25 | $10K | — | Filing → |